Search

Your search keyword '"Caramella, C."' showing total 778 results

Search Constraints

Start Over You searched for: Author "Caramella, C." Remove constraint Author: "Caramella, C."
778 results on '"Caramella, C."'

Search Results

4. Three artificial intelligence data challenges based on CT and MRI

5. Artificial intelligence solution to classify pulmonary nodules on CT

7. Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRI

9. P1.18-03 Patients with Smoking-Associated Atherosclerotic Cardiovascular Diseases: Does Prevalung Refines Eligibility for Screening?

10. P1.28-09 Definition of Resectable Stage III Non-small Cell Lung Cancer (NSCLC): A Clinical Case Review by a Pan-European Expert Panel

13. Standardised lesion segmentation for imaging biomarker quantitation:a consensus recommendation from ESR and EORTC

14. 1090P HER2 copy number variation in non-small cell lung cancer (NSCLC)

15. 941P PET-derived parameters for response assessment in neoadjuvant atezolizumab: A secondary analysis of PRINCEPS phase II trial

23. Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery

29. PO-1246 Lung SBRT after pneumonectomy

31. List of contributors

32. Preparation and characterization of polysaccharide-based nanoparticles with anticoagulant activity

37. 1355P Monitoring tumor growth rate to predict immune checkpoint inhibitors’ treatment outcome in advanced NSCLC

40. Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers (Jan , 10.1007/s00330-020-07598-8, 2021)

42. Incorporating radiomics into clinical trials: expert consensus on considerations for data-driven compared to biologically driven quantitative biomarkers

43. Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront [FP07.06]

44. Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers

45. Incorporating radiomics into clinical trials: expert consensus on considerations for data-driven compared to biologically driven quantitative biomarkers

46. Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront [FP07.06]

Catalog

Books, media, physical & digital resources